CRP and ulcerative colitis: It entails determining an appropriate target, selecting initial therapy, measuring baseline disease characteristics, monitoring treatment progress, and optimizing therapy to achieve the treatment aim.[21] Endoscopic scores such as the Mayo score and the ulcerative colitis endoscopic index of severity, and biomarkers such as fecal calprotectin and CRP are the most important effective monitoring tools.[21,22]